|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
A single center, randomized, double blinded phase I/IIa exploratory study to evaluate reactogenicity, safety, immunogenicity and dose-response of a new hepatitis B vaccine in human adult
100 Clinical Results associated with CHA Vaccine Institute
0 Patents (Medical) associated with CHA Vaccine Institute
100 Deals associated with CHA Vaccine Institute
100 Translational Medicine associated with CHA Vaccine Institute